Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract

Molecular Biology of the Cell

Volumn 18, Issue 5, 2007, Pages 1543-1553

  Freberg, Christel T ^a   Dahl, John Arne ^a   Timoskainen, Sanna ^a   Collas, Philippe ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; HISTONE H3; LYSINE; NANOG PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EMBRYO CELL; EPIGENETICS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; UPREGULATION;

ACETYLATION; CARCINOMA, EMBRYONAL; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; LYSINE; METHYLATION; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; REGULATORY SEQUENCES, NUCLEIC ACID; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 34248141152     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E07-01-0029     Document Type: Article

References (43)

1. Aalfs, J. D., Narlikar, G. J., and Kingston, R. E. (2001). Functional differences between the human ATP-dependent nucleosome remodeling proteins BRG1 and SNF2H. J. Biol. Chem. 276, 34270-34278.
2. Antequera, F. (2003). Structure, function and evolution of CpG island promoters. Cell Mol. Life Sci. 60, 1647-1658.
3. Armstrong, L., Lako, M., Dean, W., and Stojkovic, M. (2006). Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells 24, 805-814.
4. Azuara, V. et al. (2006). Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532-538.
5. Blelloch, R., Wang, Z., Meissner, A., Pollard, S., Smith, A., and Jaenisch, R. (2006). Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24, 2007-2013.
6. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., and Zhang, Y. (2002). Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039-1043.
7. Cibelli, J. B., Stice, S. L., Golueke, P. J., Kane, J. J., Jerry, J., Blackwell, C., Ponce de Leon, F., and Robl, J. M. (1998). Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat. Biotechnol. 16, 642-646.
8. Cowan, C. A., Atienza, J., Melton, D. A., and Eggan, K. (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373.
9. Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., and Pirrotta, V. (2002). Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111, 185-196.
10. 2ChIP, a quick and quantitative chromatin immunoprecipitation assay unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells Feb. 1 [Epub ahead of print].
11. Deb-Rinker, P., Ly, D., Jezierski, A., Sikorska, M., and Walker, P. R. (2005). Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J. Biol. Chem. 280, 6257-6260.
12. Feldman, N., Gerson, A., Fang, J., Li, E., Zhang, Y., Shinkai, Y., Cedar, H., and Bergman, Y. (2006). G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8, 188-194.
13. Gurdon, J. B., and Byrne, J. A. (2003). The first half-century of nuclear transplantation. Proc. Natl. Acad. Sci. USA 100, 8048-8052.
14. Gurdon, J. B., Byrne, J. A., and Simonsson, S. (2003). Nuclear reprogramming and stem cell creation. Proc. Natl. Acad. Sd. USA 100 (suppl 1), 11819-11822.
15. Håkelien, A. M., Landsverk, H. B., Robl, J. M., Skålhegg, B. S., and Collas, P. (2002). Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat. Biotechnol. 20, 460-466.
16. Hansis, C., Barreto, G., Maltry, N., and Niehrs, C. (2004). Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr. Biol. 14, 1475-1480.
17. Kikyo, N., and Wolffe, A. P. (2000). Reprogramming nuclei: insights from cloning, nuclear transfer and heterokaryons. J. Cell Sci. 113, 11-20.
18. Kimura, H., Tada, M., Nakatsuji, N., and Tada, T. (2004). Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell. Biol. 24, 5710-5720.
19. Kingston, R. E., and Narlikar, G. J. (1999). ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13, 2339-2352.
20. Lachner, M., and Jenuwein, T. (2002). The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14, 286-298.
21. Landsverk, H. B., Håkelien, A. M., Küntziger, T., Robl, J. M., Skålhegg, B. S., and Collas, P. (2002). Reprogrammed gene expression in a somatic cell-free extract. EMBO Rep. 3, 384-389.
22. Minucci, S., Botquin, V., Yeom, Y. I., Dey, A., Sylvester, I., Zand, D. J., Ohbo, K., Ozato, K., and Scholer, H. R. (1996). Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 15, 888-899.
23. Morgan, H. D., Dean, W., Coker, H. A., Reik, W., and Petersen-Mahrt, S. K. (2004). Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem. 279, 52353-52360.
24. Munsie, M. J., Michalska, A. E., O'Brien, C. M., Trounson, A. O., Pera, M. F., and Mountford, P. S. (2000). Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr. Biol. 10, 989-992.
25. Orlando, V. (2003). Polycomb, epigenomes, and control of cell identity. Cell 112, 599-606.
26. Pells, S., Di Domenico, A. I., Callagher, E. J., and McWhir, J. (2002). Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells 4, 331-338.
27. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
28. Santos, F., Zakhartchenko, V., Stojkovic, M., Peters, A., Jenuwein, T., Wolf, E., Reik, W., and Dean, W. (2003). Epigenetic marking correlates with developmental potential in cloned bovine preimplantation embryos. Curr. Biol. 13, 1116-1121.
29. Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C., Schreiber, S. L., Mellor, J., and Kouzarides, T. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411.
30. Schneider, J., and Shilatifard, A. (2006). Histone demethylation by hydroxylation: chemistry in action. ACS Chem. Biol. 1, 75-81.
31. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., and Shi, Y. (2004). Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953.
32. Simonsson, S., and Gurdon, J. (2004). DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 6, 984-990.
33. Spencer, V. A., Sun, J. M., Li, L., and Davie, J. R. (2003). Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. Methods 31, 67-75.
34. Tada, M., Tada, T., Lefebvre, L., Barton, S. C., and Surani, M. A. (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16, 6510-6520.
35. Tada, M., Takahama, Y., Abe, K., Nakastuji, N., and Tada, T. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558.
36. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
37. Taranger, C. K., Noer, A., Sorensen, A. L., Hakelien, A. M., Boquest, A. C., and Collas, P. (2005). Induction of dedifferentiation, genome-wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719-5735.
38. Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D. M., Nakano, Y., Meyer, E. M., Morel, L., Petersen, B. E., and Scott, E. W. (2002). Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545.
39. Verdone, L., Wu, J., van Riper. K., Kacherovsky, N., Vogelauer, M., Young, E. T., Grunstein, M., Di, M. E., and Caserta, M. (2002). Hyperacetylation of chromatin at the ADH2 promoter allows Adr1 to bind in repressed conditions. EMBO J. 21, 1101-1111.
40. Wakayama, T., Tabar, V., Rodriguez, I., Perry, A. C., Studer, L., and Mombaerts, P. (2001). Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292, 740-743.
41. Warnecke, P. M., Stirzaker, C., Song, J., Grunau, C., Melki, J. R., and Clark, S. J. (2002). Identification and resolution of artifacts in bisulfite sequencing. Methods 27, 101-107.
42. Wilmut, I., Beaujean, N., De Sousa, P. A., Dinnyes, A., King, T. J., Paterson, L. A., Wells, D. N., and Young, L. E. (2002). Somatic cell nuclear transfer. Nature 419, 583-586.
43. Ying, Q. L., Nichols, J., Evans, E. P., and Smith, A. G. (2002). Changing potency by spontaneous fusion. Nature 416, 545-548.